ArticlePeerJ2015

Evidence from studies in rodents and in isolated adipocytes that agonists of the chemerin receptor CMKLR1 may be beneficial in the treatment of type 2 diabetes.

Edward T Wargent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.